SYS-CON MEDIA Authors: Greg Schulz, Gilad Parann-Nissany, Kevin Benedict, RealWire News Distribution, Unitiv Blog

News Feed Item

Global Marine Biotech Market Report

DUBLIN, April 10, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/mc6tz3/global_marine) has announced the addition of the "Global Marine Biotech Market Report" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


The analysts forecast the Global Marine Biotech market to grow at a CAGR of 3.82 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the demand for natural products. The Global Marine Biotech market has also been witnessing increasing investments from venture capitalists. However, high R&D costs could pose a challenge to the growth of this market.

The report, the Global Marine Biotech Market Report, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Marine Biotech market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The emergence of marine biotech in Europe is a major trend witnessed in the Global Marine Biotech market. While the US dominates the Global Marine Biotech market, Europe has also been making significant contributions to this market. With Europe recovering from the economic crisis, the country has been making steady investments in marine biotechnology.

For instance, since 2000, the European Commission, along with the member and associated states, has worked toward the development of marine biotech research infrastructure such as providing increased access to research vessels, laboratories, or stations and integrating scientific communities for enhancing research activities.

The Marine Biotech market in Europe is also witnessing the emergence of several small and medium sized enterprises that are making significant contributions to the R&D and introduction of novel marine-based products. In addition, the European Union research policy supports several collaborative projects in marine biotechnology.

According to the report, the most important of the main drivers is the introduction of innovative products from marine sources. Such products offer solutions to a wide range of markets such as Medical, Skin Care, and Cosmetics. The introduction of marine-based products such as cosmetic ingredients, pharmaceutical products, and molecules such as enzymes, biopolymers, and biomaterials are driving the growth of the market.


Key Topics Covered:

1. Executive Summary

2. List of Abbreviations

3. Introduction

4. Market Research Methodology

5. Scope of the Report

6. Market Landscape

7. Market Segmentation

8. Geographical Segmentation

9. Vendor Landscape

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Key Vendor Analysis

17. Other Reports in this Series


Companies Mentioned:

  • Aker BioMarine AS
  • Aqua Bio Technology ASA
  • Aquapharm Biodiscovery Ltd.
  • Biotech Marine
  • CP Kelco
  • Cyanotech Corp.
  • Elan Corp. plc
  • FMC Biopolymer AS
  • Frutarom USA Inc.
  • GeoMarine Biotechnologies
  • GlycoMar Ltd.
  • Integrin Advanced Biosystems
  • Jinghua Marine Biological USA Inc.
  • Lonza Group Ltd.
  • Marinova
  • Mera Pharmaceuticals Inc.
  • New England Biolabs Inc.
  • PharmaMar SA
  • Prolume Ltd.
  • Pronova BioPharma
  • Sea Run Holdings Inc.
  • Tequesta Marine Biosciences
  • Verenium Corp.
  • and Royal DSM NV.; ABL Biotechnologies Ltd.



For more information visit http://www.researchandmarkets.com/research/mc6tz3/global_marine


Media Contact: Laura Wood , +353-1-481-1716, [email protected]


SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.